1. Home
  2. ABVE vs ATOS Comparison

ABVE vs ATOS Comparison

Compare ABVE & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Above Food Ingredients Inc.

ABVE

Above Food Ingredients Inc.

N/A

Current Price

$0.56

Market Cap

36.4M

ML Signal

N/A

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

N/A

Current Price

$6.02

Market Cap

36.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABVE
ATOS
Founded
2019
2009
Country
Canada
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.4M
36.2M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ABVE
ATOS
Price
$0.56
$6.02
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$23.00
AVG Volume (30 Days)
2.2M
61.8K
Earning Date
07-09-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,758.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$0.53
52 Week High
$6.56
$7.56

Technical Indicators

Market Signals
Indicator
ABVE
ATOS
Relative Strength Index (RSI) 35.90 59.62
Support Level N/A $0.66
Resistance Level $1.07 $6.09
Average True Range (ATR) 0.14 0.35
MACD -0.00 0.04
Stochastic Oscillator 5.40 66.46

Price Performance

Historical Comparison
ABVE
ATOS

About ABVE Above Food Ingredients Inc.

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: